CHURCH KATRINA J 4

What Happened

• Katrina J. Church, SVP & Chief Compliance Officer of Bioventus (BVS), had 4,375 restricted stock units (RSUs) convert into shares on February 15, 2026. The filing shows 4,375 shares acquired (conversion of derivative) at $0.00 per share.
• To satisfy tax withholding, 2,133 of those shares were surrendered/disposed at an implied price of $8.27 per share for a withholding value of $17,640. That leaves a net delivery of 2,242 shares to the reporting person (4,375 vested − 2,133 withheld), with an approximate net value of $18,541 based on the $8.27 price.
• This is not an open-market purchase or sale for investment purposes but routine RSU vesting with share withholding to cover taxes.

Key Details

• Transaction date: 2026-02-15; Form filed: 2026-02-18.
• Vesting/conversion: 4,375 RSUs converted to shares (transaction code M).
• Tax withholding: 2,133 shares withheld (transaction code F) valued at $8.27 each, total $17,640.
• Net shares delivered: 2,242 (4,375 − 2,133); net value ≈ $18,541 using $8.27/share.
• Footnotes: Each RSU represents a contingent right to one Class A common share; RSUs vest in four equal annual installments from Feb 15, 2024.
• Shares owned after the transaction are not specified in the supplied filing.

Context

• This is a routine equity award vesting event. The “M” entries reflect conversion/exercise of a derivative (RSU conversion), and the “F” entry shows shares withheld to cover tax liabilities (common practice, not an open-market sale).
• No indication of trading under a 10b5-1 plan or that this was an investment-motivated open-market sale; the filing reflects compensation vesting and tax withholding.